A Certificate of Analysis (COA) is the primary analytical record that accompanies a research-grade peptide. For any laboratory, physician-scientist, or institution sourcing compounds for benchwork, the COA is the document that translates a vial of lyophilized powder into a defined, characterized research material. It states what the compound is, how pure it is, how its identity was confirmed, and which specific lot the data describe. Learning to read a COA critically — rather than simply noting that one exists — is a core competency for anyone designing reproducible experiments.

This explainer walks through each section of a typical peptide COA, what the underlying analytical methods actually measure, and how to distinguish a substantive document from a decorative one. Everything below is presented in a laboratory and educational register. The compounds discussed are research materials only.

What a Certificate of Analysis Is — and Is Not

A COA is a lot-specific summary of analytical testing performed on a defined batch of material. It is not a marketing sheet, not a generic product specification, and not a substitute for a researcher's own verification when a protocol demands it. A credible COA ties measured results to a specific lot number and date, names the analytical techniques used, and reports values against stated acceptance criteria (specifications).

At minimum, a useful peptide COA should contain the following elements:

  • Product identity — the peptide or compound name and, ideally, sequence or molecular formula.
  • Lot/batch number and date — uniquely identifying the tested material.
  • Appearance — a physical description of the lyophilized solid.
  • Purity by HPLC — a chromatographic percentage, with the method noted.
  • Identity by mass spectrometry — typically ESI-MS, with observed versus expected mass.
  • Counterion / net-peptide content — where applicable (e.g., acetate or trifluoroacetate salts).
  • Specifications — the acceptance thresholds each result is measured against.
A COA without a lot number is not a COA. It is a generic claim. The entire value of the document rests on its traceability to the exact material in your hands.

Reading HPLC Purity as a Chromatographic Percentage

The purity figure on most peptide COAs is generated by reversed-phase high-performance liquid chromatography (RP-HPLC). In this technique, the dissolved sample is pushed through a hydrophobic stationary phase under a gradient of increasing organic solvent (commonly acetonitrile with an acidic modifier). Components elute at different times based on their hydrophobicity, and a detector — usually UV absorbance at 214–220 nm, where the peptide bond absorbs — records a chromatogram of peaks over time.

The reported purity is the area of the main peak expressed as a percentage of the total integrated peak area. A result of "98.5% by HPLC" means the target peak accounts for 98.5% of the detected absorbance; the remaining 1.5% reflects resolved impurities such as deletion sequences, truncated chains, or process-related byproducts.

What the purity number does and does not tell you

This is a relative, detector-dependent measurement, and several nuances matter:

  • It is method-specific. A purity value is only meaningful in the context of the gradient, column, and detection wavelength used. A robust COA names the method or references it.
  • UV detection sees only what absorbs. Non-chromophoric impurities, residual salts, or water of hydration may not appear as peaks. HPLC purity is therefore not the same as total mass purity.
  • Co-eluting species can hide. An impurity that elutes at the same retention time as the main peak can inflate apparent purity. Orthogonal confirmation by mass spectrometry helps guard against this.

For most research applications, look for a clearly stated purity with a defined specification (for example, "≥95%" or "≥99%"). A chromatogram trace included in the COA is a strong positive signal — it lets you visually assess peak symmetry, baseline quality, and the presence of shoulder peaks rather than trusting a single number in isolation.

ESI-MS: Confirming Identity Against Expected Mass

Purity tells you how much of the material is one species; it does not, on its own, confirm that the species is the correct one. That is the role of mass spectrometry, most commonly electrospray ionization mass spectrometry (ESI-MS) for peptides.

In ESI-MS, the peptide is ionized in solution and the instrument measures the mass-to-charge ratio (m/z) of the resulting ions. Peptides typically form multiple charge states (e.g., [M+H]⁺, [M+2H]²⁺, [M+3H]³⁺), and from these the software deconvolutes the observed molecular mass. The COA should report this observed mass alongside the theoretical (expected) mass calculated from the sequence.

How to interpret the mass result

The observed and expected masses should agree within the resolution of the instrument. Note the distinction between monoisotopic mass (calculated using the most abundant isotope of each element) and average mass (weighted across natural isotopic distribution); a COA should be internally consistent about which it reports. A close match between observed and expected mass is the core identity confirmation. A mismatch — even with a high HPLC purity figure — is a flag warranting clarification before the material enters any protocol.

HPLC answers "how much of one thing?" Mass spectrometry answers "is it the right thing?" A rigorous COA requires both; neither is sufficient alone.

Counterion and Net-Peptide Content

Synthetic peptides are usually isolated as salts. During purification, the peptide associates with a counterion — frequently acetate or, depending on the process, trifluoroacetate (TFA). This is one of the more frequently overlooked sections of a COA, yet it has direct consequences for any quantitative work.

The practical implication is net-peptide content: the actual mass of peptide in a given quantity of powder, after accounting for counterion, bound water, and residual salts. A vial labeled "10 mg" may contain meaningfully less than 10 mg of peptide if a substantial fraction of the weight is counterion and moisture. Net-peptide content (sometimes reported as "peptide content," often determined by amino acid analysis or nitrogen/UV methods) is what allows accurate molar calculations.

  • Counterion identity matters for studies sensitive to the salt form. TFA, for instance, is a known consideration in certain assay systems, which is why some workflows specify acetate salts.
  • Net-peptide content matters whenever concentration or molar quantity is part of the experimental design — which is to say, almost always in quantitative research.

A COA that reports counterion type and net-peptide content demonstrates a higher level of analytical characterization than one that omits them.

Appearance, Lot, and Date: The Traceability Backbone

Appearance is a simple but genuine quality checkpoint. Most research peptides are described as a "white to off-white lyophilized powder." On receipt, the material should match that description. Discoloration, clumping, or visible moisture are observations worth noting against the COA.

The lot/batch number and date of analysis are the spine of the entire document. Because each synthesis batch is characterized independently, a COA is only valid for the lot it names. Two vials of the same compound from different lots can — and routinely do — carry different purity percentages and impurity profiles.

Why lot-specific documentation is non-negotiable

Reproducibility in the laboratory depends on knowing precisely what was used. Lot-specific COAs support several practices central to good research conduct:

  • Experimental traceability — you can record the exact lot and its analytical profile in your notebook or methods section.
  • Batch-to-batch comparison — variation between lots can be detected rather than silently confounding results.
  • Audit and verification — institutional and quality-management reviews can tie data back to characterized material.

A supplier that issues a single, generic "typical" COA for all batches is providing a specification sheet, not a certificate of analysis. The distinction is fundamental.

A Practical Checklist for Vetting a COA

When a COA arrives, a disciplined review takes only a few minutes:

  • Does the lot number and date match the vial and uniquely identify the batch?
  • Is HPLC purity stated with a method reference, a specification, and ideally a chromatogram?
  • Is identity confirmed by ESI-MS, with observed mass agreeing with expected mass?
  • Are counterion type and net-peptide content reported where applicable?
  • Is appearance described, and does the received material match?
  • Is there evidence of third-party or independent testing where the supplier claims it?

Reading a COA well is ultimately about converting documentation into confidence. The numbers on the page are only as useful as your ability to interpret what they measure, what they omit, and how they trace back to the specific material on your bench. For research that demands reproducibility, that interpretive skill is not optional — it is part of the method.

References

  • United States Pharmacopeia (USP), General Chapters on chromatography and biotechnology-derived articles.
  • U.S. Food and Drug Administration, guidance documents on analytical procedures and method validation (educational reference).
  • International Council for Harmonisation (ICH), Q2 and Q6 series on analytical validation and specifications.
  • Journal of Chromatography A — peer-reviewed literature on reversed-phase HPLC of peptides.
  • Journal of the American Society for Mass Spectrometry — methodology of electrospray ionization mass spectrometry.
  • Analytical Chemistry (American Chemical Society) — fundamentals of peptide identity and purity analysis.

For Research Use Only — Not for human use or consumption. All compounds referenced are research materials intended exclusively for laboratory and research purposes.